Federal · Amendment

Regulations exempting certain precursors and controlled substances from federal drug law have been repealed

Regulations Exempting Certain Precursors and Controlled Substances from the Application of the Controlled Drugs and Substances Act — under the CONTROLLED DRUGS AND SUBSTANCES ACT

Recorded date: October 1, 2026
Detected: November 17, 2026. Verify commencement in the official source.

Health CareConsumer & Business

Plain-language summary · AI-assisted

The Regulations Exempting Certain Precursors and Controlled Substances from the Application of the Controlled Drugs and Substances Act have been formally repealed. Previously, this instrument exempted a small list of specific substances—including bezitramide, piritramide, and propylhexedrine—from the full reach of the Controlled Drugs and Substances Act. With the repeal, those exemptions no longer exist, meaning any activity involving those substances will be subject to the standard requirements of the Act. Businesses, researchers, or individuals who relied on these exemptions should review whether their current practices comply with the Act's full requirements.

Who this affects
pharmaceutical manufacturers · chemical suppliers handling listed precursors · researchers working with exempted substances · health care product distributors

Check the official text
SOR/97-229 on the official source ↗

This page isn't an official version of the law and isn't legal advice. Summaries may omit details. Verify the dates and provisions that apply to you against the official source.

View this law's change history · Follow this law by RSS

Keep up with what changes.

The free weekly digest brings together published changes across our coverage. Confirm your email to subscribe.